Elite Pharmaceuticals Inc (ELTP)

[imanjen13]

The upcoming 10Q will replace revenues from license fees with the term "direct sales" to Pharmacies and Institutions to reflect the commencement of the selling by Elite under its own label which began on April 1. See Page F-6 of 10Q for quarter ending June 30.
The direct sales number will be of great interest to investors both old and new.

It will also be interesting to see if the CFO will now convert the 10Q now based on the regular calendar year rather than the fiscal year which ends on March 31. That would make this report the third quarter and I believe Carter would have to revise the previous quarters. If not this report, I expect the change would occur on the New Year.